Answer
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Gilead is indicated for adults aged 18 years and over with HIV-1 who are antiretroviral treatment-naïve or whose HIV-1 has no known mutations associated with resistance to any of its three antiretroviral agents.
Sources for this answer
- Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Gilead150 mg/150 mg/200 mg/245 mg film-coated tabletsGilead Sciences Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 32Document updated
Sources checked